Calculate Your Salary Ranking
Home > Biosynexus Incorporated Salary

Biosynexus Incorporated Salary
  • 55
  • 32
  • 100

Biosynexus Incorporated average salary is $43,055, median salary is $43,000 with a salary range from $29,000 to $85,000.
Biosynexus Incorporated salaries are collected from government agencies and companies. Each salary is associated with a real job position. Biosynexus Incorporated salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Low
29,000
Average
43,055
Median
43,000
High
85,000
Total 2 Biosynexus Incorporated Salaries. Sorted by Date, page 1
Ranked By:
Job Title Salaries City Year More Info
Research Associate 29,000-46,509 Gaithersburg, MD, 20877 2010 Biosynexus Incorporated Research Associate Salaries (23)
Biosynexus Incorporated Gaithersburg, MD Salaries
Clinical Project Manager 85,000-85,000 Gaithersburg, MD, 20877 2010 Biosynexus Incorporated Clinical Project Manager Salaries (1)
Biosynexus Incorporated Gaithersburg, MD Salaries
1
Calculate how much you could earn

It's FREE. Based on your input and our analysis.    How we do it?

All fields are required for calculation accuracy.

  • We will send you an email to access your personalized report.
  • We won’t share your email address
Recent Biosynexus Incorporated Salaries (April 30, 2016)
Assistant Professor University of Oklahoma $42,860 Norman, OK, 73019 01/05/2015
General OMRON $65,998 Houston, TX, 77001 09/07/2015

Biosynexus Incorporated salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.

Real Jobs Salary - Salary List
Biosynexus Incorporated Information
  • Biosynexus Incorporated
  • Industry: BioTech/Drugs
  • City: Gaithersburg, MD
  • Biosynexus Incorporated is a biopharmaceutical company that is commercializing a portfolio of protein-based products ¨C monoclonal antibodies, enzymes and peptides ¨C for the prevention and treatment of hospital acquired ¨C nosocomial ¨C infections. The company has focused its initial efforts on developing products for the prevention and treatment of staphylococcal infections.